Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer
Journal of Clinical Investigation - Cardiology
SEPTEMBER 3, 2024
Obesity is a known driver of endometrial cancer. In this issue of the JCI, Gómez-Banoy and colleagues investigated a cohort of patients with advanced endometrial cancer treated with immune checkpoint inhibitors targeting the interaction between programmed cell death receptor-1 (PD-1) and its ligand (PD-L1).
Let's personalize your content